熊本大学大学院生命科学研究部 遺伝子機能応用学分野

研究実績

学会発表（国際学会）

International conference 2025

Select

ASN Kidney Week 2025（2025.11.5-9）Houston, USA

"Dapagliflozin with Losartan but Not Olmesartan Has Add-On Protective Effect in Experimental Alport Syndrome"
Jun Horizono, Mary Ann Suico, Shota Kaseda, Tsuyoshi Shuto, Hirofumi Kai

"Mild Electrical Stimulation and Heat Shock Promotes Recovery from AKI in Mice"
Haruki Tsuhako, Mary Ann Suico, Tsuyoshi Shuto, Hirofumi Kai

"Early Variable Gene of Alport Syndrome, Tnfsf15, Is a Protective Factor and Effect Modifier Against Renal Pathology”
Aimi Owaki, Shota Kaseda, Ryuichi Nishinakamura, Mary Ann Suico, Tsuyoshi Shuto, Hirofumi Kai

The 2025 International Workshop on Alport Syndrome - Beijing（2025.9.5～7）Beijing, China

An early variable gene in Alport syndrome, Tnfsf15, is a pathoprotective factor in proteinuria and glomerular damage and effect modifier of renal pathology
〇Aimi Owaki, Shota Kaseda, Ryuichi Nishinakamura, Mary Ann Suico, Tsuyoshi Shuto, Hirofumi Kai

Dapagliflozin with losartan but not olmesartan has
an add-on protective effect in experimental Alport syndrome
○Keito Mizumoto, Jun Horizono, Mary Ann Suico, Shota Kaseda, Tsuyoshi Shuto, and Hirofumi Kai